Clinical Research

Clinical Trials Drug Development Patient Care Randomized Controlled Trials Epidemiology Observational Studies Patient Outcomes Diagnostic Tools Meta-Analysis Drug Trials

3 ARTICLES

yesterday

Blood Pressure Drugs Linked to Better Outcomes on Vedolizumab for Ulcerative Colitis

The study links ACE inhibitors or ARBs to a blood‑vessel inflammation pathway that could be targeted to lower complications if randomized trials confirm benefit.

4 ARTICLES

2d ago

FDA Approves Sunharbo, First Factor XIa Anticoagulant, to Prevent Repeat Strokes

4 ARTICLES

2d ago

MAR001 Cuts Triglycerides Dramatically in Phase 2b Trial

4 ARTICLES

4d ago

Small Study Suggests Pill Could Put Hormone‑Driven High Blood Pressure Into Long‑Term Remission

6 ARTICLES

5d ago

Two High‑Profile Heart Trials Fail to Cut Events Despite Big Biomarker Drops

5 ARTICLES

6d ago

FDA Grants Accelerated Approval to Rybrevant Faspro for Recurrent and Metastatic HNSCC

4 ARTICLES

last wk.

Self‑Powered Toothbrush Generates Charge That Kills Plaque in Early Tests

4 ARTICLES

last wk.

Pulmonary Hypertension Linked to Distinct Cerebellar–Frontal Brain Injury

4 ARTICLES

last wk.

FDA Accepts uniQure’s Huntington’s Gene Therapy for Priority Review, Sets May 1, 2027 Decision Date

3 ARTICLES

2w ago

MIT Shows Implanted Magnets Can Track Muscle Motion to Improve Prosthetic Control

3 ARTICLES

2w ago

Symbolic‑AI Digital Twins Predict Triple‑Negative Breast Cancer Responses

3 ARTICLES

2w ago

FDA Approves Talazoparib With Enzalutamide for HRR‑Mutated Early Metastatic Prostate Cancer

3 ARTICLES

2w ago

Innovent Advances Two ADC Programs After ESMO Presentations

3 ARTICLES

2w ago

Nature Medicine Paper Shows Vβ‑Directed Bispecific Expands Targeted T Cells and Triggers Tumor Responses

5 ARTICLES

3w ago

Targeted Ultrasound Lowers Delusions in Small Schizophrenia Trial

5 ARTICLES

3w ago

AstraZeneca and Oracle Announce Global AI Collaboration to Use Real-World Data in Care and Trials

3 ARTICLES

4w ago

INmune Bio and Quantum Computing Inc. Team Up to Run XPro Data Through a Quantum Optimizer

3 ARTICLES

4w ago

Low-Dose LSD Improves Sustained Attention in Women but Not Men

3 ARTICLES

4w ago

FDA Approves Weltruza, First Monthly Subcutaneous Olanzapine for Schizophrenia

3 ARTICLES

4w ago

Tovinontrine Shows Target Engagement but Fails to Lower NT‑proBNP at High Dose in Phase II

Clinical Research

Blood Pressure Drugs Linked to Better Outcomes on Vedolizumab for Ulcerative Colitis

FDA Approves Sunharbo, First Factor XIa Anticoagulant, to Prevent Repeat Strokes

MAR001 Cuts Triglycerides Dramatically in Phase 2b Trial

Small Study Suggests Pill Could Put Hormone‑Driven High Blood Pressure Into Long‑Term Remission

Two High‑Profile Heart Trials Fail to Cut Events Despite Big Biomarker Drops

FDA Grants Accelerated Approval to Rybrevant Faspro for Recurrent and Metastatic HNSCC

Self‑Powered Toothbrush Generates Charge That Kills Plaque in Early Tests

Pulmonary Hypertension Linked to Distinct Cerebellar–Frontal Brain Injury

FDA Accepts uniQure’s Huntington’s Gene Therapy for Priority Review, Sets May 1, 2027 Decision Date

MIT Shows Implanted Magnets Can Track Muscle Motion to Improve Prosthetic Control

Never miss stories about

Clinical Research

Symbolic‑AI Digital Twins Predict Triple‑Negative Breast Cancer Responses

FDA Approves Talazoparib With Enzalutamide for HRR‑Mutated Early Metastatic Prostate Cancer

Innovent Advances Two ADC Programs After ESMO Presentations

Nature Medicine Paper Shows Vβ‑Directed Bispecific Expands Targeted T Cells and Triggers Tumor Responses

Targeted Ultrasound Lowers Delusions in Small Schizophrenia Trial

AstraZeneca and Oracle Announce Global AI Collaboration to Use Real-World Data in Care and Trials

INmune Bio and Quantum Computing Inc. Team Up to Run XPro Data Through a Quantum Optimizer

Low-Dose LSD Improves Sustained Attention in Women but Not Men

FDA Approves Weltruza, First Monthly Subcutaneous Olanzapine for Schizophrenia

Tovinontrine Shows Target Engagement but Fails to Lower NT‑proBNP at High Dose in Phase II

Never miss stories about

Clinical Research